- Sem Dados
Português
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Los Alamos National Laboratory (LANL) has developed a method for a quantum light emitter that stacks two different atomically thin materials together to achieve a light source that produces a stream of circularly polarized single photons. These light sources can in turn be used for a variety of quantum information and communication applications.According to Los Alamos researcher Han Htoon, the wor...
Abstract: A groundbreaking discovery by CNR Nanotec and scientists from the University of Warsaw has revealed a robust method for creating long-lived quantum fluids using semiconductor photonic gratings. This study, published in the journal Nature Physics, marks a significant step forward in simulating complex systems through unique polariton droplets that demonstrate stability in lifespan and rec...
Recently, a group of researchers from the University of Cambridge developed an innovative method of using high-energy lasers to improve 3D printing of metals. This discovery has the potential to change the way we design and manufacture complex metal objects.3D printing has completely changed the landscape of the manufacturing industry. However, it faces obstacles, especially in terms of the charac...
A project at Macquarie University has demonstrated a way to narrow the linewidth of a laser beam by a factor of over ten thousand.Published in APL Photonics, the technique offers a promising route toward ultra-narrow linewidth lasers for potential use in a wide range of pump-pulse systems.Laser linewidth measures how precisely a beam of light maintains its frequency and color purity, and narrow-li...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...